Ethricef T 250mg/31.25mg Injection
Marketer
Ethyrial Pharmaceuticals
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Ethricef T 250mg/31.25mg Injection
Cephalexin/Sulbactam injection (250mg/31.25mg) is a dual-action antibiotic. It's used to combat a range of bacterial infections by inhibiting microbial proliferation. This injection must be administered only by a healthcare provider. Consistent adherence to the prescribed dosage schedule is crucial; completing the full course is vital, even with symptom improvement. Premature cessation may compromise its effectiveness. Potential side effects include, but aren't limited to, nausea, vomiting, diarrhea, and dyspepsia. Report any worsening symptoms immediately. Seek urgent medical attention for allergic reactions (e.g., rash, itching, edema, dyspnea). Inform your doctor of all current medications, including those for pre-existing conditions. Pregnant or lactating individuals should seek medical advice before use. Alcohol consumption should be avoided due to potential increased drowsiness. While it typically doesn't affect driving ability, refrain from driving if experiencing drowsiness or dizziness. Adequate rest, a nutritious diet, and ample hydration promote faster recovery. Your physician may order blood tests and other diagnostics to monitor the medication's impact.
Primary Ingredients of Ethricef T 250mg/31.25mg Injection
No text provided to rephrase.
Uses of Ethricef T 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Ethricef T 250mg/31.25mg Injection:
Administering this medication will be performed by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Ethricef T 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Ethricef T 250mg/31.25mg Injection:
This medication will be administered by your physician or registered nurse; please refrain from self-medicating.
How Ethricef T 250mg/31.25mg Injection works:
Ceftriaxone and Tazobactum, combined as Ethricef T 250mg/31.25mg Injection, offer a targeted antibacterial approach. Ceftriaxone, an antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to survive. The beta-lactamase inhibitor, Tazobactum, counteracts bacterial resistance mechanisms, thereby boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from concurrent use of Ethricef T 250mg/31.25mg Injection and alcohol.
PregnancySAFE IF PRESCRIBED
Ethricef T 250mg/31.25mg injections are typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or absent harm to offspring; nevertheless, clinical data from human pregnancies are scarce.
Breast feedingCAUTION
The antibiotic injection Ethricef T (250mg/31.25mg) requires careful consideration when breastfeeding. Mothers should discontinue breastfeeding for the duration of treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
Ethricef T 250mg/31.25mg injections can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Ethricef T 250mg/31.25mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
The injectable medication Ethricef T 250mg/31.25mg requires careful administration in individuals with significant hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Dosage alteration for Ethricef T 250mg/31.25mg Injection is not suggested for those with mild or moderately compromised liver function.
What if you forget to take Ethricef T 250mg/31.25mg Injection :
Should you inadvertently skip a dose of Ethricef T 250mg/31.25mg Injection, seek immediate medical advice.
Facts to Know About Ethricef T 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Infectious Disease Treatments |
3,018 People bought this recently